Alexion says no need to revise earnings, shares rise

Jan 4 (Reuters) - Alexion Pharmaceuticals Inc on

Wednesday filed its delayed third-quarter 2016 financial report

with U.S. regulators and said an investigation into allegations

regarding sales...

Read more